Which insulin tends to peak and pose a risk for hypoglycemia at 30 minutes after dosing?

Humalog, or insulin lispro, is classified as a rapid-acting insulin. After administration, it starts to work very quickly, typically within 15 minutes, reaching its peak effect around 30 to 90 minutes post-injection. This quick onset and peak time creates a significant risk for hypoglycemia, especially if a meal is delayed after the insulin has been taken.

Rapid-acting insulins like Humalog are crucial for managing blood glucose levels during meals, but the timing of meals in relation to medication administration is essential to prevent episodes of hypoglycemia. The effectiveness and rapid peak of rapid-acting insulin make it a vital tool in diabetes management, but it also necessitates careful monitoring of blood sugar levels.